Aptinyx Inc
Biotechnology
Healthcare
APTX
67.72M shares
NASDAQ US
traded
08 Apr 2022
listed
yes
open
1.16
52 week high
3.62
high
1.42
52 week low
1.38
low
1.15
growth
-48.51%
previous Close
2.34
P/E ratio
-4
market cap
183M
div yield
0
usd
Sep 2021
qoq
revenue
4.93K
-99.90 %
net incoming
-21.23M
-7.12 %
eps
-0.31
-6.90 %
eps surprise
1.37 %
net profit margin
-430823.86 %
-430432.00 %
operating incoming
-21.21M
-6.75 %
net change in cash
-4.01M
77.20 %
cash on hand
125M
-3.05 %
cost of revenue
top top